Status:
WITHDRAWN
Outcomes of Transcatheter ASD Closure Guided by 3D-TEE
Lead Sponsor:
Assiut University
Conditions:
ASD2(Secundum Atrial Septal Defect)
Eligibility:
All Genders
Brief Summary
Atrial Septal Defect (ASD) is a common cardiac diagnosis among adults.Three-dimensional transesophageal echocardiography (3D-TEE) improve the visualization of ASD, its rims and surrounding structures ...
Detailed Description
The investigators will include 80 patients in a prospective cohort study . For all patients the following study tools will be done: 1. Written consent. 2. Detailed history including Age, sex, sympto...
Eligibility Criteria
Inclusion
- Patients with suitable indication for ASD closure according to recent guidelines :
- Impaired functional capacity.
- Right atrial and/or RV enlargement.
- Left-to-right shunt with \[Qp: Qs\] ≥1.5:1.
- Paradoxical embolism.
- Patients with isolated secundum ASD with sufficient rims suitable for device closure.
Exclusion
- Small ASD with Qp/Qs \<1.5:1 or no signs of RV volume overload
- A single defect too large for closure (\>38 mm)
- Multiple ASDs unsuitable for percutaneous closure.
- Anterior, posterior, superior, or inferior rim \<5 mm.
- Abnormal pulmonary venous drainage.
- Associated structural heart disease requiring cardiac surgery.
- ASD with severe pulmonary arterial hypertension and bidirectional or right-to-left shunting.
- Intracardiac thrombi diagnosed by echocardiography.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03867708
Start Date
December 1 2020
End Date
March 1 2022
Last Update
September 21 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.